Shanghai Junshi Biosciences (1877.HK) Earnings Analysis

Shanghai Junshi Biosciences (1877.HK) next reports earnings on 2026-08-27. Trailing P/E -57.25.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 1877.HK next report earnings?

Next earnings date2026-08-27
Consensus EPS estimaten/a
Revenue estimate0.83B

1877.HK earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-27-0.02273 HKDn/an/an/a
2026-02-27-0.27812 HKDn/an/an/a
2025-08-26-0.18024 HKDn/an/an/a
2025-04-25-0.25731 HKDn/an/an/a
2024-08-30-0.38617 HKDn/an/an/a

1877.HK valuation and analyst view

Trailing P/E-57.25
Trailing EPS-0.64419 HKD
Price / book6.47
Dividend yield0.00%
Market cap27.05B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Shanghai Junshi Biosciences (1877.HK)'s next earnings date?

Shanghai Junshi Biosciences is next scheduled to report on 2026-08-27 and revenue estimate of 0.83B.

Did 1877.HK beat earnings last quarter?

Consensus estimate data was not available for 1877.HK's 2026-04-27 report.

What is 1877.HK's current P/E ratio and EPS?

1877.HK trades at a trailing P/E of -57.25 on trailing EPS of -0.6441942509508966 HKD.

What do analysts rate 1877.HK?

1877.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.